3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
8
Brain Neoplasms
7
Sarcoma
5
Carcinoma, Hepatocellular
4
Solid Tumor, Adult
3
Carcinoma, Non-Small-Cell Lung
3
Rhabdomyosarcoma
2
Pituitary Neoplasms
2
Meningioma
2
Liver Neoplasms
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Breast Neoplasms
2
Bone Neoplasms
2
Thymus Neoplasms
1
Thymoma
1
Thoracic Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Recurrence
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Pinealoma
1
Pediatric Cancer Patients
1
Parotid Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
Exercise
8
salicylhydroxamic acid
2
High-Intensity Interval Training
2
Electrocardiography
2
Echocardiography
2
sacubitril and valsartan sodium hydrate drug combination
1
mitoquinone
1
epicatechin gallate
1
candesartan
1
Therapeutics
1
Surveys and Questionnaires
1
Secondary Prevention
1
Restraint, Physical
1
Rehabilitation
1
Proton Therapy
1
Proteins
1
Palliative Care
1
Methods
1
Medical History Taking
1
Magnetic Resonance Spectroscopy
1
Laser-Doppler Flowmetry
1
Ivabradine
1
Heart Rate
1
Heart Function Tests
1
Exercise Test
1
Echocardiography, Stress
1
Diagnostic Imaging
1
Cardiac Rehabilitation
1
Blood Pressure
1
Blood Cell Count
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cardiotoxicity
×
Proton Therapy
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled